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Summary: In the Netherlands 30% of all women of reproductive age are habitual smokers. One third of these
women continue to smoke during pregnancy. Tobacco smoke consists of more than 3600 different compounds. One
of its chief pharmacologically active ingredients is nicotine of which 60% is metabolized to cotinine. Cotinine is
the best available biochemical marker of nicotine consumption because it is specific for tobacco smoke exposure
and it has a relatively long mean t./2 of 15 hours.
In the present study nicotine and cotinine concentrations were measured in 25 smoking and 25 non-smoking healthy
pregnant women. In all 25 non-smoking pregnant women nicotine and cotinine levels were < 10mg/l. Light
smokers (< 10 cigarettes/day) were found to have nicotine blood concentrations < 10mg/l and cotinine levels
varying between 40 and 99 mg/1. Heavy smokers (^ 10 cigarettes/day) had nicotine concentrations < 10 mg/1, but
high cotinine levels varying from 115 to 199 mg/1.
Cotinine was also determined in 25 neonates of non-smoking mothers and in 34 neonates of smoking mothers. In
9 of these 34 newborns the relationship between maternal and neonatal cotinine concentrations was investigated.
Cotinine levels in neonates born to non-smokers and to women who smoked less than 10 cigarettes/day were
below the detection limit of 10 mg/1. Cotinine values in neonates whose mothers smoked ^ 10 cigarettes/day
were significantly higher than in those whose mothers smoked < 10 cigarettes/day, but significantly lower than in
their mothers.
The results of this study confirm that cotinine is more useful than nicotine in discriminating non-smokers, light and
heavy smokers. Cotinine concentrations were significantly lower in the neonates than in their mothers, but there
was a strong positive linear relationship between maternal and neonatal cotinine concentrations.
Introduction
In the Netherlands 30% of all women of reproductive levels of carboxyhaemoglobin in fetal blood (8). These
age are habitual smokers. Surveys of smoking during effects are mainly caused by nicotine, tar and carbon
pregnancy have shown that the prevalence of smoking monoxide. Nicotine also exerts significant haemody-
in this group of women is high (1). Several studies have namic effects in the mother by increasing arterial blood
assessed that while approximately 40% of smokers may pressure and heart rate (9).
reduce their level of tobacco consumption during preg- _.- . A « . . . , , ,, . . , „ , , σ r σ Fifty to ninety percent of nicotine m smoke is absorbednancy, one third of all pregnant women continue t o , , ι j ^ j * j - i _ ^ i j i _ i, _ _ N _ _. . , j . , - , by the smokers and can be detected in the blood shortlysmoke (2,3). Nicotine dependence is the most powerful ;. .. /1AX . , . . .. . . , i r i_ '. . . \, ' , , , . ,A. after smoking (10). In adults the elimination half-life ofdriving force for continue the habit (4). . . f, / . · * ι i™ · jnicotine in blood is approximately 120 minutes, and
Tobacco smoke consists of more than 3600 different 60% of the substance is metabolized to cotinine (11, 12),
compounds (5) and its composition varies with the type of which 10o/0 is excreted as such in the urine (12). Coti-
of tobacco and the way it is smoked. The chief pharma- nine is slowly cieared from the body and is primarily
cologically active ingredients are nicotine and tar. An eliminated by the liver (13). Renal clearance accounts
average cigarette contains approximately 1 mg nicotine. for ^0^ 17ο/0 of total clearance. Because of the low
Cigarette smoking during pregnancy is associated with rate of metabolism and renal excretion, the half-life (t/2)
a well-documented increase in perinatal mortality and of cotinine is approximately 15 hours (10—20 h) (10).
morbidity rates (6, 7). Most of the adverse effects of As a consequence of the long t./2 there is relatively little
smoking are related to chronic fetal hypoxia arising fluctuation in blood concentration throughout the day.
from decreased uteroplacental perfusion and increased Various biochemical procedures have been used to esti-
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mate exposure to tobacco smoke: blood concentrations
of nicotine, cotinine, carbon monoxide (CO) carboxy-
haemoglobin (COHb) and thiocyanate have been deter-
mined. Levels of thiocyanate, CO and COHb are easy
to determine but may be artificially raised through expo-
sures unrelated to smoking, such as traffic exhaust gases
(CO) and diet (thiocyanate) (14).
A few studies have attempted to compare the various
biochemical tests. Hill et al. (15) concluded that plasma
and serum cotinine are valid indicators of smoke absorp-
tion, while COHb levels correlate well with cigarette
smoke inhalation. Pojer et al. (16) reached the same
conclusion. Janns et al. (14) are of the opinion that mea-
surements of cotinine are best used in discriminating
smokers from non-smokers.
While the effects of nicotine on the pregnant mother and
her fetus have already been discussed, little is known
about the effects of cotinine. Benowitz et al. (11) ob-
served no change in blood pressure, heart rate or skin
temperature, effects extremely sensitive to low concen-
trations of nicotine. Keenan et al. (17) assessed that coti-
nine has psychoactive properties. Clark et al. (18) found
that the pharmacodynamic activity of cotinine is only
1/100 of that of nicotine.
Even less is known about the effect of smoking on the
actual concentrations of cotinine in smoking pregnant
women and their newborns. For this purpose cotinine
levels were measured simultaneously in maternal blood
plasma (study group 1) and cord blood plasma (study
group 2).
Subjects and Methods
Nicotine and cotinine concentrations were measured in the venous
blood plasma of 25 smoking and 25 non-smoking healthy pregnant
women, in the second trimester of their pregnancy. This checkpoint
was chosen because Sexton et al. (19) indicated that by the time a
smoker reaches her second trimester of pregnancy she will either
stop smoking or will continue to smoke until delivery. A second
study group consisted of 25 neonates born to non-smoking mothers
and 34 neonates bom to smoking mothers. In 9 of these cases, the
mothers were also investigated, in order to determine the relation-
ship between maternal and neonatal cotinine concentrations. In the
second group only cotinine levels were measured. Venous samples
were taken because values for venous blood have been published
and are available for comparison. Nicotine as well as cotinine
levels were determined by gas chromatography (20) nitrogen-phos-
phorus detection of nicotine and cotinine. The measurements were
conducted by the Department of Toxicology, University Hospital,
Maastricht, The Netherlands. A Hewlett Packard 5890A gas Chro-
matograph was used. The detection limit for nicotine was 10 mg/1.
Duplicity: nicotine 5.6%/cotinine 3.6%. Reproducibility: nicotine
8.4%/cotinine 5.3% The reference ranges for light smokers (< 10
cigarettes/day): nicotine < 10 mg/1/cotinine 10-100 mg/1 and
heavy smokers (^ 10 cigarettes/day): nicotine > 10 mg/1/cotinine
^ 100 mg/1, are mentioned in table 1.
Blood samples were drawn between 8.30 and 9.00 a.m., at least
one hour after the last cigarette was smoked. Venous blood samples
of the newborns were obtained from the clamped umbilical cord
immediately after delivery. The samples of their mothers were
Tab. 1 Nicotine and cotinine values in 13 light and 12 heavy
smokers
Pa- Light smokers Pa- Heavy smokers
tient (< 10 cigarettes/day) tient (> 10 cigarettes/day)
No. No.
























































drawn during labour, 2—5 hours after the last cigarette was
smoked.
The Mann-Whiiney-U test was used to compare the differences be-
tween the cotinine concentrations in neonates born to smoking and
non-smoking mothers.
The Wilcoxon signed rank test was used to test the significance of
differences in the plasma cotinine concentration between smoking
mothers and their newborns. The Spearman rank correlation coeffi-
cient was used to estimate the correlation between maternal and
neonatal cotinine concentrations.
Results
In all 25 non-smoking pregnant women nicotine and cot-
inine levels were < 10 mg/1. The smoking group con-
sisted of 13 women who reported smoking < 10 ciga-
rettes/day (light smokers) and 12 women who reported
smoking 10 or more cigarettes/day. The light smokers
were found to have nicotine blood levels < 10 mg/1 and
cotinine levels varying between 40 and 99 mg/1. Heavy
smokers had nicotine levels < 10 mg/1, but high cotinine
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Fig. 1 Cotinine concentrations in umbilical vein plasma in neo-
nates born to smoking mothers.
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levels varying from 115 to 199 mg/1. Of the women who
reported smoking more than 15 cigarettes/day (heavy
smokers), 3 had cotinine values > 175 mg/1.
Cotinine levels in neonates of non-smokers and women
who smoked less than 10 cigarettes/day were below the
detection limit of 10 mg/L Figure 1 shows the cotinine
concentrations in neonates in relation to their mothers'
smoking habits. Cotinine values in neonates whose
mothers smoked ^ 10 cigarettes/day were significantly
higher (p < 0.001) than in those whose mothers smoked
< 10 cigarettes/day, but significantly lower than in their
mothers (p < 0.01). There seems to be a threshold
around 10 cigarettes/day. The cotinine concentrations in
the 9 smoking mothers and their infants are shown in
table 2. The correlation between cotinine concentrations
in maternal and umbilical vein plasma is illustrated in
figure 2. The Spearman rank correlation coefficient was
0.912 with a p-value of 0.001.
Discussion
The cotinine measurements in our first study group con-
firm that cotinine is more useful than nicotine for
discriminating between non-smokers, light smokers and
heavy smokers. This is in accordance with earlier find-
ings (21—25). Nicotine levels in smokers were below
the detection limit of 10 mg/1 because blood samples
were taken at least one hour after the last cigarette was
smoked. In adults the elimination half-life of nicotine in
blood is approximately 120 minutes. For comparison
with other studies, it is important to state that none of
the women in the present study underestimated their
smoking habits.
The amount of products of tobacco smoke transmitted
to the fetus varies consistently, depending on the propor-
tion of each cigarette consumed, frequency of puffing,
depth of inhalation and maternal metabolism (14, 15).
After birth, the neonate's own metabolism affects the
levels and duration of exposure to smoke products. For
this reason, cotinine measurements were carried out in
the plasma of neonates born to smokers and non-smok-
ers in parallel with measurements in maternal plasma.
The results of this study show that cotinine is easily
transferred to the neonatal compartment. Cotinine con-
centrations were significantly lower in the neonates than
in their mothers (p < 0.01), but there was a strong posi-
tive linear relationship between maternal and neonatal
cotinine concentrations (rs = 0.912, p < 0.001). Don-
nenfeld et al. (26) found that fetal cotinine concentra-
tions were about 90% of maternal values throughout
gestation. Luck et al. (27) found similar cotinine concen-
trations in smoking mothers and their neonates.
Cotinine concentrations were below the detection limit
of 10 mg/1 in neonates born to non-smoking mothers
and in neonates born to mothers who smoked less than
10 cigarettes/day. Infants of mothers who smoked > 10
cigarettes/day had significantly higher cotinine levels
(p < 0.001). There seems to be a threshold around 10
cigarettes/day.
Bardy et al. (28) measured tobacco exposure during
pregnancy, in order to determine the effects on neonates
of maternal smoking. They found a quantitative dose/
effect relationship between tobacco exposure (cotinine
concentrations) and a decrease in the gestational age at
birth and the size of the neonate. It might be fortuitous
that Peacock et al. (29) found a threshold of 13 ciga-
rettes per day for the effect of smoking on birth weight.
In conclusion, cotinine is more useful than nicotine for
discriminating between non-smokers, light smokers and
heavy smokers. Cotinine, the principal metabolite of ni-
cotine, readily appears in measurable concentrations in
the neonate when his/her mother smokes ̂  10 cigarettes
per day. Cotinine concentrations in neonates are signifi-
cantly lower than in their mothers, but there is a strong
positive linear relationship between cotinine concentra-











Fig. 2 Correlation between cotinine concentrations (mg/1) in um-
bilical vein and maternal vein plasma (rs = 0.912, p < 0.001).
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